Here are relevant reports on : topical-antibiotics-market
-
Companion Animal Pharmaceuticals Market by Animal Type (Dogs, Cats, Horses), Route of Administration (Oral, Injectable, Topical), Indication (Antibiotics, Parasiticides), Distribution Channel (Veterinary Hospitals & Clinics) & Region - Global Forecasts to 2027
The global companion animal pharmaceuticals market in terms of revenue was estimated to be worth $14.4 billion in 2022 and is poised to reach $19.6 billion by 2027, growing at a CAGR of 6.3% from 2022 to 2027. Major players operating in the market Zoetis Inc. (US), Merck & Co., Inc. (US), Boehringer Ingelheim GmbH (Germany), Elanco Animal Health Incorporated (US), Ceva Santé Animale (France), Virbac (France), Vetoquinol S.A. (France), Dechra Pharmaceuticals plc (UK) are some of the market players.
- Published: March 2023
- Price: $ 4950
- TOC Available:
-
Synthetic Feed Additives Market by Type (Amino Acids, Phosphates, Vitamins, Acidifiers, Enzymes, Mycotoxin Detoxifiers, Flavors & Sweeteners, Antibiotics, Minerals, Antioxidants, Nonprotein nitrogen, Preservatives), Livestock, Form, Function, and Region – Global Forecast to 2030
The synthetic feed additives market is estimated to be USD 33.88 billion in 2025 and is projected to reach USD 44.46 billion by 2030, at a CAGR of 5.6%. The Key Players Cargill (US), ADM (US), Evonik Industries (Germany), BASF SE (Germany), dsm-firmenich (Switzerland), Ajinomoto Co. (Japan), Novonesis Group (Denmark), Adisseo (France), Nutreco (Netherlands), Kemin Industries (US), Lallemand (Canada), Alltech (US), Bentoli (US), and Novus International (US).
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Customized Premixes Market by Type (Vitamins, Minerals, Amino Acids, Nucleotides, Antibiotics, Fibers), Application (Beverages, Dairy Products, Bakery & Confectionery Products, Nutraceuticals), Form, Function and Region - Global Forecast to 2027
According to MarketsandMarkets, the global customized premixes market is projected to reach USD 2.5 billion by 2027, with a CAGR of 5.5% during the forecast period. This report includes a study on the marketing and development strategies, along with the product portfolios of leading companies. It consists of profiles of leading companies, such as DSM (The Netherlands), Glanbia PLC (Ireland), Corbion (The Netherlands), Vitablend Nederland BV (The Netherlands), SternVitamin GmbH & Co. KG (Germany), Jubilant Ingrevia Limited (India), Hexagon Nutrition Limited (India), Prinova Group LLC (US), ADM (US), and Cargill, Incorporated (US).
- Published: December 2022
- Price: $ 4950
- TOC Available:
-
Pet Animals Feed & Feed Additive Market By Types (Antibiotics, Vitamins, Antioxidants, Amino Acids, Feed Enzymes, Acidifiers) By Ancillary Supplements (Prebiotics & Probiotics), Trends & Forecast 2013-2018
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Latin America Pharmaceutical Drug Delivery Market by Route of Administration [Injectable (Prefilled Syringe, Self Injection Devices), Oral (Tablet, Capsule, Liquid), Topical, Buccal, Nasal, Rectal], Application (Cancer, Diabetes, CVD) - Forecast to 2031
The latin america pharmaceutical drug delivery market, valued at USD 72.7BN in 2025, stood at USD 75.3BN in 2026 and is projected to advance at a resilient CAGR of 6.3% from 2026 to 2031, culminating in a forecasted valuation of USD 102.1BN by the end of the period. Some of the prominent players in the Latin America pharmaceutical drug delivery market include Pfizer Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Novartis AG (Switzerland), Sanofi (France), AstraZeneca (UK), GSK Plc (UK), Eurofarma (Brazil), Bayer AG (Germany), EMS (Brazil), BD (US), Teva Pharmaceutical Industries Ltd. (Israel), and Hypera Pharma (Brazil).
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Dental Anesthetics Market by Drug Type (Lidocaine, Mepivacaine, Articaine, Bupivacaine, Mepivacaine, Prilocaine), Route of Administration (Topical, Injectable, Syringes, Needles), End User (Hospitals, Clinics, Others), Region - Global Forecast to 2030
The global dental anesthetics market, valued at US$1.43 billion in 2024, stood at US$1.48 billion in 2025 and is projected to advance at a resilient CAGR of 4.0% from 2025 to 2030, culminating in a forecasted valuation of US$1.80 billion by the end of the period. Several factors are driving the global market for dental anesthetics
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Topical Pharmaceutical Packaging Market by Type, Material (Plastic, Glass, Metal, Paper, Aluminum), Product Type (Bottles, Caps & Closures, Inhalers), Drug Type, Closure Type, Application (Dermatology, Ophthalmology), and Region - Global Forecast To 2030
The topical pharmaceutical packaging market is projected to reach USD 29.5 billion by 2030 from USD 13.8 billion in 2025, at a CAGR of 16.5% during the forecast period. The key players include
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Sugar-Based Excipients Market by Product (Actual Sugars, Sugar Alcohols, Artificial Sweeteners), Type (Powder/Granule, Crystal, Syrup), Functionality (Filler & Diluent, Tonicity Agents), Formulation (Oral, Topical, Parenteral) - Global Forecast to 2021
The global sugar excipients market is projected to reach USD 1,060.6 Million by 2021 from USD 860.6 Billion in 2016, at a CAGR of 4.3% from 2016 to 2021. The sugar excipients market is expected to witness significant growth in the coming years due to the increasing use of co-processed excipients, rapid growth in the generics market due to the patent expiration of many blockbuster drugs, and increasing development of orally disintegrating tablets (ODTs).
- Published: December 2016
- Price: $ 4950
- TOC Available:
-
Topical Drug Delivery Market by Product (Formulation (Semi-solid, Emulsion), Transdermal Patch, Microneedle Patch, Drug-in-adhesive, Matrix Patch), Application (Dermal, Ophthalmic, Nasal, Vaginal, Rectal), End User, Region - Global Forecast to 2030
The global topical drug delivery market, valued at US$247.3 billion in 2024, stood at US$268.4 billion in 2025 and is projected to advance at a resilient CAGR of 8.8% from 2025 to 2030, culminating in a forecasted valuation of US$408.97 billion by the end of the period. Market growth is driven by the rising prevalence of dermatological disorders, growing demand for non-invasive drug administration, and increasing adoption of advanced formulations such as gels, creams, transdermal patches, and foams.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Ophthalmology Drugs Market by Molecule (Faricimab, Aflibercept, Ranibizumab), Modality (Monoclonal Antibodies & Fusion Proteins), RoA (Intravitreal, Topical), Indication (AMD, Diabetic Retinopathy (DR), DME), End User - Global Forecast to 2030
The global ophthalmology drugs market, valued at US$18.34 billion in 2024, stood at US$19.52 billion in 2025 and is projected to advance at a resilient CAGR of 6.1% from 2025 to 2030, culminating in a forecasted valuation of US$26.28 billion by the end of the period.
- Published: June 2025
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
